GBDC:NASDAQGolub Capital BDC, Inc. Analysis
Data as of 2026-05-19 - not real-time
$12.91
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Golub Capital BDC trades just above its 20‑day SMA (13.28) and below the 200‑day SMA (13.57), indicating a price that is still below long‑term averages. RSI sits at 44, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, pointing to short‑term downside pressure. Volume is decreasing, and the stock is hovering near the identified support level of $12.87, which could act as a floor if buying interest returns.
The company offers an eye‑catching dividend yield of 11.15% but the payout ratio exceeds 190%, raising serious questions about sustainability. A high debt‑to‑equity ratio of 125× and a max drawdown of over 22% underscore financial leverage risk, even though operating cash flow remains solid at $526 M.
Analyst consensus is a “Buy” with a mean target price of $13.75, implying modest upside (~6.5%) versus current price, while forward P/E of 10.2 suggests cheaper valuation relative to peers. The market sentiment index shows “Extreme Greed,” which may be pricing in the high yield but could reverse if dividend cuts materialize.
The company offers an eye‑catching dividend yield of 11.15% but the payout ratio exceeds 190%, raising serious questions about sustainability. A high debt‑to‑equity ratio of 125× and a max drawdown of over 22% underscore financial leverage risk, even though operating cash flow remains solid at $526 M.
Analyst consensus is a “Buy” with a mean target price of $13.75, implying modest upside (~6.5%) versus current price, while forward P/E of 10.2 suggests cheaper valuation relative to peers. The market sentiment index shows “Extreme Greed,” which may be pricing in the high yield but could reverse if dividend cuts materialize.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support
- Bearish MACD signal
- Dividend payout ratio above 100%
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward P/E of 10.2 indicating valuation discount
- Potential upside to analyst target
- Strong operating cash flow supporting dividend
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage and credit quality risk
- Uncertain dividend sustainability
- Stable asset‑management franchise in US middle‑market
Key Metrics & Analysis
Financial Health
Revenue Growth-12.00%
Profit Margin24.64%
P/E Ratio17.0
ROE5.26%
ROA4.66%
Debt/Equity125.46
P/B Ratio0.9
Op. Cash Flow$526.5M
Free Cash Flow$298.0M
Industry P/E16.7
Technical Analysis
TrendNeutral
RSI43.9
Support$12.86
Resistance$13.91
MA 20$13.28
MA 50$12.89
MA 200$13.57
MACDBearish
VolumeDecreasing
Fear & Greed Index89.61
Valuation
Target Price$13.75
Upside/Downside6.51%
GradeFair
TypeValue
Dividend Yield11.15%
Risk Assessment
Beta0.60
Volatility23.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.